Influence of biologics on carbohydrate metabolism and risk of diabetes [Влияние генно-инженерных биологических препаратов на углеводный обмен и...
Кондратиева Л. В., Попкова Т. В., Насонов Е. Л.
Научно-практическая ревматология
Т. 57, Вып. 2, С. 222-228
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.14412/1995-4484-2019-222-228
Аннотация:
In the article the analysis of the literature on the impact of biologics of different groups (inhibitors of tumor necrosis factor α, tocilizumab, abatacept, rituximab and interleukin 1 inhibitors) on the production of insulin by the pancreas, insulin resistance and the risk of development of the 2nd type diabetes in patients with rheumatic diseases. © 2019 Ima-Press Publishing House. All rights reserved.
Ключевые слова:
Ankylosing spondylitis; Diabetes mellitus; Genetically engineered biological preparations; Insulin resistance; Psoriatic arthritis; Rheumatoid arthritis
abatacept; biological product; insulin; interleukin 1 derivative; rituximab; tocilizumab; tumor necrosis factor inhibitor; Article; carbohydrate metabolism; diabetes mellitus; human; insulin resistance; non insulin dependent diabetes mellitus; pancreas; rheumatic disease; risk assessment
Язык текста: Русский
ISSN: 1995-4492
Кондратиева Л. В.
Попкова Т. В.
Насонов Е. Л. Евгений Львович 1948-
Kondratieva L. V.
Popkova T. V.
Nasonov E. L. Evgenij L`vovich 1948-
Influence of biologics on carbohydrate metabolism and risk of diabetes [Влияние генно-инженерных биологических препаратов на углеводный обмен и риск развития сахарного диабета]
Influence of biologics on carbohydrate metabolism and risk of diabetes [Влияние генно-инженерных биологических препаратов на углеводный обмен и...
Текст визуальный непосредственный
Научно-практическая ревматология
ИМА-Пресс
Т. 57, Вып. 2 С. 222-228
2019
Статья
Ankylosing spondylitis Diabetes mellitus Genetically engineered biological preparations Insulin resistance Psoriatic arthritis Rheumatoid arthritis
abatacept biological product insulin interleukin 1 derivative rituximab tocilizumab tumor necrosis factor inhibitor Article carbohydrate metabolism diabetes mellitus human insulin resistance non insulin dependent diabetes mellitus pancreas rheumatic disease risk assessment
In the article the analysis of the literature on the impact of biologics of different groups (inhibitors of tumor necrosis factor α, tocilizumab, abatacept, rituximab and interleukin 1 inhibitors) on the production of insulin by the pancreas, insulin resistance and the risk of development of the 2nd type diabetes in patients with rheumatic diseases. © 2019 Ima-Press Publishing House. All rights reserved.